cement - hdfc securities - 3qfy20e results previe… · star cement** 0.7 13.6 23.2 5,923 (2.9)...
TRANSCRIPT
Cement
3QFY20E Results Preview
10 Jan 2020
Saurabh Dugar [email protected] +91-22-3021 2072
Rajesh Kumar Ravi [email protected] +91-22-3021 2077
2
3QFY20E RESULTS PREVIEW
Q3FY20E: Pricing and cost tailwinds continue Another quarter of flattish sales growth: Cement demand
remained flattish YoY for the third consecutive qtr, on account of
continued slowdown in construction activities. We estimate the
aggregate demand for the 11 cement companies under coverage
(adjusted for Century Textiles vols in UltraTech) to grow a modest
2% YoY (better than the 2% decline in 1HFY20).
Mixed pricing trends YoY across regions: As per our channel checks,
cement prices fell QoQ across markets owing to weak demand.
Trade prices in 3Q fell ~2-3% QoQ across the north/central regions
while it slid by ~5-7% QoQ across east/west/south markets. On YoY
basis, this implies that north/central/west trade prices are up
11/6/5% YoY while that east/south prices are down 8/3% YoY.
Prices in NE region and Chhattisgarh have fallen only marginally
while prices in AP/T markets have declined ~10%+ QoQ.
Opex to decline YoY on account of lower energy costs : We
estimate companies’ input cost to moderate QoQ/YoY on full
benefits of low cost fuel. This along with, reduced freight cost YoY
(benefits from lower diesel prices and absence of busy-season
railway surcharge) should keep opex low. However, we expect fixed
cost inflation to remain high (on subdued vol growth). Thus we
expect total opex to decline 2% YoY (for our coverage universe).
Op margins to remain healthy: Despite muted demand and
subsequent price slide QoQ, we estimate average unitary EBITDA for
our coverage universe at a robust Rs 954/MT (+25% YoY) – a 7-year
high for Dec-qtr. We estimate healthy margins for north/central/Guj
based cos (on strong regional pricing), while margins for AP/T based
cos t are hit hard (dual impact of weak vols and pricing). We have
plotted macro trends for cement prices and opex items in this report.
Aggregate EBITDA to surge 31% YoY in 3QFY20E driven by robust
margins for sales in the north/central/Gujarat markets and overall
lower opex. Thus, in our coverage universe we see solid EBITDA
growth for UltraTech, Ambuja, Shree Cement, JK Lakshmi and JK
Cement. We estimate flattish EBITDA for south and east focused
companies (weak pricing impact). However, we estimate sharp
EBITDA decline in case of Deccan Cement (poor sales and pricing in
AP/T) and Star Cement (weak pricing and high cost inflation).
Estimate revisions and outlook: Given the lower than estimated
demand and pricing across south and east markets, we have
reduced profit estimates and TPs for Dalmia Bharat, Orient
Cements, Star Cement and Deccan Cements. We have also trimmed
Shree Cement’s PAT to factor in the recent QIP. We maintain our
estimates/TP for all other cos. We remain bullish on the sector
owing to continued cost tailwinds and as we expect demand to
recover which will support realisations. In our view, the healthy
pricing in north/central markets should sustain owing to high
regional clinker utilisation and low supply influx. Price stability in
south and east markets is contingent upon double digit demand
recovery, in our view.
Top picks: UltraTech , JK Cement and Dalmia Bharat
3
3QFY20E RESULTS PREVIEW
Financial Summary: 3QFY20E
Source: Company, HDFC sec Inst Research ** Consolidated estimates ^ Q4CY19 Estimates
Y/E March (Rs mn)
Net Sales (Rs mn) EBITDA (Rs mn) EBITDA Margin (%) Adj. PAT (Rs mn) Adj. EPS (Rs)
3Q FY20E
YoY (%)
QoQ (%)
3Q FY20E
YoY (%)
QoQ (%)
3Q FY20E
YoY (pp)
QoQ (pp)
3Q FY20E
YoY (%)
QoQ (%)
3Q FY20E
YoY (%)
QoQ (%)
ACC** ^ 40,320 3.5 14.3 5,328 4.3 (4.4) 13.2 0.1 (2.6) 2,997 17.6 (1.0) 15.9 17.6 (1.0)
Ambuja ^ 31,409 9.7 19.6 5,874 45.4 33.5 18.7 4.6 2.0 3,509 35.3 49.6 1.8 35.3 49.6
Dalmia ** Bharat
22,517 3.7 0.7 4,186 7.9 (11.9) 18.6 0.7 (2.7) (69) (0.4)
Deccan Cem 1,184 (31.6) (11.8) 101 (55.7) (36.8) 8.6 (4.7) (3.4) 34 (69.9) (63.0) 4.9 (69.9) (63.0)
JK Cement 14,023 10.1 11.8 2,712 28.8 6.7 19.3 2.8 (0.9) 1,104 81.3 1.5 14.3 81.3 1.5
JK Lakshmi 10,017 7.1 7.1 1,463 48.9 (1.6) 14.6 4.1 (1.3) 429 190.9 (6.5) 3.6 190.9 (6.5)
Orient Cem 5,652 (1.0) 9.7 508 34.1 (5.3) 9.0 2.3 (1.4) (95) (0.5)
Ramco Cem 12,607 4.2 (4.2) 2,404 12.4 (18.6) 19.1 1.4 (3.4) 1,128 11.6 (32.9) 4.8 11.6 (32.9)
Shree Cement 29,381 5.7 4.9 8,390 21.6 (0.6) 28.6 3.7 (1.6) 3,432 22.0 11.1 95.1 17.8 7.2
Star Cement ** 4,620 10.9 20.8 1,008 (17.3) 56.7 21.8 (7.5) 5.0 760 (7.7) 70.2 1.8 (7.7) 70.2
UltraTech Cem**
108,998 16.7 13.3 22,535 55.0 17.5 20.7 5.1 0.7 8,231 100.7 42.3 28.5 91.0 33.9
Aggregate 280,727 9.5 10.7 54,509 31.3 7.6 19.4 3.2 (0.6) 29,691 55.6 23.7
4
3QFY20E RESULTS PREVIEW
Operational Summary: 3QFY20E
Source: Company, HDFC sec Inst Research ** Consolidated estimates ^ Q4CY19 Estimates
Y/E March (Rs mn)
Sales Volume (mn MT) NSR (Rs/MT) EBITDA (Rs/MT) Opex (Rs/MT)
3Q FY20E
YoY (%)
QoQ (%)
2Q FY20E
YoY (%)
QoQ (%)
2Q FY20E
YoY (pp)
QoQ (pp)
2Q FY20E
YoY (%)
QoQ (%)
ACC** ^ 7.7 2.0 18.8 4,820 0.9 (4.0) 663 5.7 (21.4) 4,157 0.2 (0.5)
Ambuja ^ 6.4 5.2 23.3 4,871 4.3 (3.0) 911 38.2 8.3 3,960 (1.3) (5.3)
Dalmia Bharat ** 4.7 6.0 6.0 4,752 (2.2) (5.0) 883 1.8 (16.9) 3,869 (3.1) (1.8)
Deccan Cement 0.3 (30.8) (5.9) 3,533 (1.2) (6.3) 302 (36.1) (32.8) 3,231 4.1 (2.7)
JK Cement 2.6 3.2 15.2 5,440 6.7 (2.9) 1,052 24.8 (7.3) 4,388 3.1 (1.8)
JK Lakshmi 2.3 (1.3) 10.4 4,405 8.6 (3.0) 643 50.9 (10.8) 3,762 3.6 (1.5)
Orient Cement 1.4 (5.0) 15.5 3,942 4.2 (5.0) 354 41.1 (18.0) 3,588 1.6 (3.5)
Ramco Cements 2.8 2.0 2.9 4,485 1.9 (5.0) 858 8.6 (13.0) 3,627 0.4 (2.9)
Shree Cement 6.2 4.5 8.4 4,513 4.6 (3.0) 1,353 27.0 (6.7) 3,160 (2.7) (1.3)
Star Cement** 0.7 13.6 23.2 5,923 (2.9) (1.5) 1,357 (27.2) 27.1 4,566 7.9 (7.7)
UltraTech Cem** 22.1 14.3 18.0 4,942 2.2 (4.0) 1,022 35.7 (0.5) 3,920 (4.0) (4.9)
Aggregate 57.3 7.0 15.0 4,814 2.8 (3.6) 947 25.0 (5.9) 3,866 (1.5) (3.1)
5
3QFY20E RESULTS PREVIEW
Demand & Price trends
Industry vol growth remains flattish for the 3rd qtr in a row Weak demand has pulled down utilisation marginally YoY
Cement prices continue to decline QoQ owing to weak demand- south and east are most impacted YoY Pan India prices continue to decline: down 5% QoQ, Up 2% YoY
(15.0)
(10.0)
(5.0)
-
5.0
10.0
15.0
20.0
Jun
-14
Oct
-14
Feb
-15
Jun
-15
Oct
-15
Feb
-16
Jun
-16
Oct
-16
Feb
-17
Jun
-17
Oct
-17
Feb
-18
Jun
-18
Oct
-18
Feb
-19
Jun
-19
Oct
-19
Industry volume growth%
40.0
50.0
60.0
70.0
80.0
90.0
100.0
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Utilisation (RHS)%
200
250
300
350
400
Jan
-18
Feb
-18
Mar
-18
Apr
-18
May
-18
Jun-
18
Jul-
18
Aug
-18
Sep
-18
Oct
-18
Nov
-18
Dec
-18
Jan
-19
Feb
-19
Mar
-19
Apr
-19
May
-19
Jun-
19
Jul-
19
Aug
-19
Sep
-19
Oct
-19
Nov
-19
Dec
-19
North Central East West SouthRs/bag
200
250
300
350
400
Jan
-18
Feb
-18
Ma
r-1
8A
pr-1
8M
ay-1
8Ju
n-1
8Ju
l-1
8A
ug-1
8S
ep
-18
Oct
-18
Nov
-18
Dec
-18
Jan
-19
Feb
-19
Mar
-19
Apr
-19
May
-19
Jun
-19
Jul-
19
Aug
-19
Sep
-19
Oct
-19
Nov
-19
Dec
-19
Pan IndiaRs/bag
Source: Bloomberg, HDFC sec Inst Research
6
3QFY20E RESULTS PREVIEW
Energy Cost trends
Crude price is down 9% YoY, despite recovering 2% QoQ Thus diesel prices are down 6% YoY (+1% QoQ)
Imported petcoke prices continue to fall in 3Q: down 26/14% YoY/QoQ
Even domestic petcoke prices continue to slide: down 32/8% YoY/QoQ
0
20
40
60
80
100
Mar
-15
Jun-
15
Sep
-15
De
c-1
5
Mar
-16
Jun-
16
Se
p-1
6
Dec
-16
Mar
-17
Jun-
17
Sep
-17
Dec
-17
Mar
-18
Jun-
18
Sep
-18
Dec
-18
Mar
-19
Jun-
19
Se
p-1
9
Dec
-19
USD/Bbl Brent Price
40
45
50
55
60
65
70
75
80
Dec
-15
Mar
-16
Jun
-16
Sep
-16
Dec
-16
Mar
-17
Jun
-17
Sep
-17
Dec
-17
Ma
r-1
8
Jun
-18
Sep
-18
Dec
-18
Ma
r-1
9
Jun
-19
Sep
-19
Dec
-19
(Rs/Litre) Average diesel price (daily)Trailing Three Month Avg price
0
20
40
60
80
100
120
140
De
c-1
5
Mar
-16
Jun
-16
Sep
-16
Dec
-16
Mar
-17
Jun
-17
Sep
-17
De
c-1
7
Mar
-18
Jun
-18
Se
p-1
8
Dec
-18
Mar
-19
Jun
-19
Sep
-19
Dec
-19
USA Gulf Petcoke Saudi PetcokeUSD/MT
3,000
4,000
5,000
6,000
7,000
8,000
9,000
10,000
Dec
-15
Mar
-16
Jun-
16
Sep
-16
De
c-1
6
Mar
-17
Jun-
17
Sep
-17
Dec
-17
Ma
r-1
8
Jun-
18
Sep
-18
Dec
-18
Mar
-19
Jun-
19
Sep
-19
Dec
-19
Rs/MT Domestic Petcoke
Source: Bloomberg, Industry, HDFC sec Inst Research
7
3QFY20E RESULTS PREVIEW
Energy Cost trends
Indonesian coal prices are down 11/2% YoY/QoQ South African coal prices are down 22% YoY, despite 13% QoQ recovery
40
50
60
70
80
90
100
De
c-1
5
Mar
-16
Jun
-16
Sep
-16
De
c-1
6
Mar
-17
Jun
-17
Sep
-17
De
c-1
7
Mar
-18
Jun
-18
Sep
-18
De
c-1
8
Mar
-19
Jun
-19
Sep
-19
De
c-1
9
USD/MT Indonesian Coal
0
20
40
60
80
100
120
De
c-1
5
Mar
-16
Jun
-16
Sep
-16
De
c-1
6
Mar
-17
Jun
-17
Sep
-17
De
c-1
7
Mar
-18
Jun
-18
Sep
-18
De
c-1
8
Mar
-19
Jun
-19
Sep
-19
De
c-1
9
USD/MT South African Coal
Source: Bloomberg, Industry, HDFC sec Inst Research
8
3QFY20E RESULTS PREVIEW
Operating Performance Trends
We expect 2% YoY vol growth for our coverage universe… …and avg utilisation at ~77% vs 79/68% YoY/QoQ
While NSR continues to rise YoY, the momentum has reduced in 3Q Ex- freight NSR growth has also moderated in 3Q
(5.0)
-
5.0
10.0
15.0
20.0
25.0
Jun
-15
Sep
-15
De
c-1
5
Mar
-16
Jun
-16
Sep
-16
De
c-1
6
Mar
-17
Jun
-17
Sep
-17
De
c-1
7
Mar
-18
Jun
-18
Sep
-18
De
c-1
8
Mar
-19
Jun
-19
Sep
-19
De
c-1
9
Vol growth YoY (coverage universe )%
-
20.0
40.0
60.0
80.0
100.0
-
10.0
20.0
30.0
40.0
50.0
60.0
70.0
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Total Sales Vol Utilisation (RHS)Mn MT %
-15
-10
-5
0
5
10
15
20
2,000
2,500
3,000
3,500
4,000
4,500
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Avg NSR Ex-freight NSR Ex-freight YoY (RHS)Rs/ MT %
-10
-5
0
5
10
15
2,000
2,500
3,000
3,500
4,000
4,500
5,000
5,500
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Avg NSR NSR YoY (RHS)Rs/ MT %
Source: Industry, Company, HDFC sec Inst Research
9
3QFY20E RESULTS PREVIEW
Operating Performance Trends
Falling fuel/diesel prices has accelerated input cost reduction Unitary fixed costs inflation to remain high owing to subdued volume growth YoY
-15
-10
-5
0
5
10
15
400
600
800
1,000
1,200
1,400
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Avg Fixed costs Fixed costs YoY (RHS)Rs/MT %
-15
-10
-5
0
5
10
3,000
3,200
3,400
3,600
3,800
4,000
4,200
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Avg Opex Opex YoY (RHS)Rs/MT %
-
5.0
10.0
15.0
20.0
25.0
30.0
400
600
800
1,000
1,200
1,400
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Avg Unitary EBITDA OPM (RHS)Rs/MT %
-15
-10
-5
0
5
10
15
20
1,000
1,200
1,400
1,600
1,800
2,000
Jun
-14
Sep
-14
De
c-1
4M
ar-1
5Ju
n-1
5Se
p-1
5D
ec-
15
Mar
-16
Jun
-16
Sep
-16
De
c-1
6M
ar-1
7Ju
n-1
7Se
p-1
7D
ec-
17
Mar
-18
Jun
-18
Sep
-18
De
c-1
8M
ar-1
9Ju
n-1
9Se
p-1
9D
ec-
19
Avg Input cost Input Cost YoY (RHS)Rs/MT %
Overall opex is expected to decline further in 3Q Op margin remains strong in 3QFY20 owing to pricing and cost tailwinds – Seasonally 7-yr high !!
Source: Industry, Company, HDFC sec Inst Research
10
3QFY20E RESULTS PREVIEW
3QFY20E: Company wise expectations
COMPANY 3QFY20E
OUTLOOK WHAT’S LIKELY KEY MONITORABLES
ACC (Q4CY19E) GOOD
We estimate consol Rev/EBIDTA/APAT to grow by 4/4/18% YoY to Rs 40.3/5.3/3.0 bn resp.
We expect volumes to grow by 2% YoY to 7.7 mn MT while NSR to fall by 4% QoQ to Rs 4,820/MT(+1% YoY).
We estimate Opex to remain flattish YoY, thus leading to unitary EBITDA of Rs 663/MT (+6% YoY,-21% QoQ)
Status on various on-going expansions
Ambuja Cement (Q4CY19E)
STRONG
We estimate standalone Rev/EBIDTA/APAT to grow by 10/45/35% YoY to Rs 31.4/5.9/3.5 bn resp.
We expect volume to grow by 5% YoY to 6.4mn MT. We est NSR to fall by 3% QoQ (+4% YoY) to Rs4,871/MT. Large exposure to north & central markets is driving up NSR gains YoY
We estimate opex to fall 1% YoY at Rs , thus leading to unitary EBITDA of Rs 911/MT (+38% YoY, +8% QoQ).
Status on various on-going expansions
Dalmia Bharat AVERAGE
We estimate consol Rev/EBIDTA to grow by 4/8% YoY to Rs 22.5/4.2 bn resp. However, we estimate marginal net loss owing to large capital charges.
Volumes are expected to grow by 6% YoY to 4.7mn MT while weak pricing in south and east should pull down NSR is expected to fall by 5% QoQ (-2% YoY) to Rs 4,752/MT.
We estimate Opex to fall 3% YoY at Rs 3,869/MT, thus leading to an unitary EBITDA of Rs 883/MT (+2% YoY, -17% QoQ).
Progress of various organic expansions in east
Status on Murli plant acquisitions Status on the mutual fund recovery
11
3QFY20E RESULTS PREVIEW
COMPANY 3QFY20E
OUTLOOK WHAT’S LIKELY KEY MONITORABLES
Deccan Cement WEAK
We estimate Rev/EBIDTA/APAT to fall sharply by 32/56/70% YoY to Rs 1,184/101/34 mn resp.
We expect volume to fall by 31% YoY to 0.34mn MT and NSR to fall by 6% QoQ (-1% YoY) to Rs 3,533/MT on weak demand in AP/T markets
We estimate opex to increase by 4% YoY at Rs 3,231/MT, thus leading to low unitary EBITDA of Rs 302/MT (down 36/33% YoY/QoQ).
Progress on WHRS and new expansion plans
JK Cement STRONG
We estimate standalone Rev/EBIDTA/APAT to increase by 10/29/81% YoY to Rs 14.0/2.7/1.1 bn resp.
We expect Grey cement volumes/ NSR to firm up 3/10% YoY leading to unitary EBITDA of ~Rs 650/MT (+60% YoY). Thus, we estimate grey EBITDA to surge ~65% YoY.
We estimate standalone white cem/putty vol to rise 2% YoY, leading to flattish segmental EBITDA YoY.
Status of various expansions in the northern/ Gujarat markets
Progress on white cement sales from UAE plant into India and African countries
JK Lakshmi Cement STRONG
We estimate Rev/EBIDTA/APAT to grow by 7/49/191% YoY to Rs 10.0/1.5/0.4 bn resp.
We expect volume to fall by 1% YoY to 2.27mn MT and NSR to fall by 3% QoQ (+9% YoY) to Rs 4,405/MT. Large presence in North/Guj markets is boosting realisation.
We estimate Opex to increase by 4% YoY at Rs 3,762/MT, thus leading to unitary EBITDA of Rs 643/MT (+51% YoY, -11% QoQ).
Future cement capacity expansion plans
Ramp-up of Udaipur Cement
3QFY20E: Company wise expectations
12
3QFY20E RESULTS PREVIEW
COMPANY 3QFY20E
OUTLOOK WHAT’S LIKELY KEY MONITORABLES
Orient Cement WEAK
We estimate Rev to fall by 1% YoY to Rs 5.7 bn, while we estimate EBITDA to recover 34% YoY (on low base) to Rs 0.51 bn. APAT to still remain negative at Rs 95 mn from Rs 138 mn.
We expect volumes to fall by 5% YoY to 1.4mn MT on weak demand in south and Maharashtra. Even NSR should fall by 5% QoQ (+4% YoY on low base) to Rs 3,942/MT.
We est opex to rise 2% YoY at Rs 3,588/MT, thus leading to unitary EBITDA of Rs 354/MT (+41% YoY, -18% QoQ)
Expansion plans – organic/ inorganic
Ramco Cements GOOD
We estimate Rev /EBITDA/APAT to grow 4/12/12% YoY to Rs 12.6/2.4/1.1 bn.
We expect volumes to notch up 2% YoY to 2.8mn MT but NSR to fall by 5% QoQ (+2% YoY) to Rs 4,485/MT.
We est opex to remain flattish at ~Rs 3,600/MT, leading to unitary EBITDA of Rs 858/MT (+9% YoY, -13% QoQ).
Status on various on-going expansions in the east/south markets
Shree Cement STRONG
We estimate Rev /EBITDA/APAT to grow 6/22/22% YoY to Rs 29.4/8.4/3.4 bn.
We expect cement volumes to increase by 5% YoY to 6.2mn MT but NSR to cool off 3% QoQ (+5% YoY) to Rs 4,513/MT.
We est opex to fall 3% YoY to Rs 3,160/MT, leading to unitary EBITDA of Rs 1,353/MT (+27% YoY, -7% QoQ).
Ramp-up at southern plants, Organic/ inorganic expansion plans
3QFY20E: Company wise expectations
13
3QFY20E RESULTS PREVIEW
COMPANY 3QFY20E
OUTLOOK WHAT’S LIKELY KEY MONITORABLES
Star Cement AVERAGE
While we estimate consol Rev to grow 11% YoY to Rs 4.6 bn, we est EBITDA/APAT to fall 17/8% YoY to Rs 1.0/0.8 bn resp.
While sales volumes are up 14% YoY to 0.74mn MT, we estimate NSR to fall 2/3% QoQ/YoY to Rs 5,923/MT.
We est opex to inflate 6% YoY Rs 3,076/MT, leading to unitary EBITDA of Rs 1,357/MT (-27% YoY, +27% QoQ).
Coal mining situation /availability in Meghalaya post SC ruling to resume legal mining in the state
Status on Star’s Siliguri grinding expansion and plans on brownfield expansion in NE region
UltraTech Cement STRONG
We estimate consol Rev /EBITDA/APAT to grow by 17/55/101% YoY to Rs 109.0/22.5/8.2 bn resp.
We expect cement volumes to increase by 14% YoY to 22.1 mn MT (adjusted for Century, we est 2% YoY vol growth). We model in 4% QoQ NSR fall (+2% YoY) to Rs 4,942/MT.
We est opex to decline 4% Rs 3,920/MT, leading to unitary EBITDA of Rs 1,022/MT YoY (+36% YoY, -1% QoQ).
Progress on Bara grinding expansion Ramp-up at acquired cement plants of
Binani Cement and Century Textiles
3QFY20E: Company wise expectations
14
3QFY20E RESULTS PREVIEW
Estimates & Target Price revisions
FY20E FY21E FY22E
Old New % Ch Old New % Ch Old New % Ch
Revenue (Rs bn) 99.81 98.41 (1.4) 111.73 106.81 (4.4) 99.81 98.41 (1.4)
EBITDA (Rs bn) 23.14 22.21 (4.0) 24.98 21.98 (12.0) 23.14 22.21 (4.0)
APAT (Rs bn) 4.19 3.02 (27.9) 5.05 2.72 (46.0) 4.19 3.02 (27.9)
AEPS (Rs/share) 21.8 15.7 (27.9) 26.2 14.1 (46.0) 32.9 18.6 (43.4)
Target Price (Rs/share) 1,500 1,275 (15.0)
Dalmia Bharat
FY20E FY21E FY22E
Old New % Ch Old New % Ch Old New % Ch
Revenue (Rs bn) 6,707 5,941 (11.4) 7,249 6,548 (9.7) 9,290 8,269 (11.0)
EBITDA (Rs bn) 1,174 881 (24.9) 1,294 1,110 (14.2) 1,554 1,359 (12.6)
APAT (Rs bn) 720 504 (30.0) 733 601 (18.0) 655 525 (19.8)
AEPS (Rs/share) 51.4 36.0 (30.0) 52.3 42.9 (18.0) 59.3 52.7 (11.0)
Target Price (Rs/share) 610 520 (14.7)
Deccan Cement
Owing to weak pricing across south and east markets and delays in Murli acquisition, we trim FY21 vol estimates by 2% and FY20/21/22E NSR est by ~1-2% each. Thus, we lower our consol EBITDA est by 4/12/4% resp, leading to TP downgrade to Rs 1275 (12x Sep’21E EBITDA).
We cut our EBITDA estimates for FY20/21/22 by 25/14/13% each owing to weak sales and pricing in the AP/T markets. We have cut vol estimates ~9-10% each and FY20/21 NSR by 3/1% resp. Thus, we lower TP to Rs 520 (6x Sep’21E EBITDA).
Source: Company, HDFC sec Inst Research
15
3QFY20E RESULTS PREVIEW
Estimates & Target Price revisions
FY20E FY21E FY22E
Old New % Ch Old New % Ch Old New % Ch
Revenue (Rs bn) 26.30 24.60 (6.5) 28.57 26.71 (6.5) 31.05 29.30 (5.6)
EBITDA (Rs bn) 4.27 3.62 (15.1) 4.84 4.16 (14.0) 5.28 4.65 (12.0)
APAT (Rs bn) 1.27 0.80 (37.0) 1.78 1.29 (27.4) 2.34 1.96 (16.5)
AEPS (Rs/share) 6.2 3.9 (37.0) 8.7 6.3 (27.4) 11.4 9.5 (16.5)
Target Price (Rs/share) 150 120 (20.0)
Orient Cement
FY20E FY21E FY22E
Old New % Ch Old New % Ch Old New % Ch
Revenue (Rs bn) 125.11 125.11 0.0 142.43 142.43 0.0 159.14 159.14 0.0
EBITDA (Rs bn) 37.83 37.83 0.0 42.25 42.25 0.0 45.39 45.39 0.0
APAT (Rs bn) 17.43 17.43 0.0 19.53 19.53 0.0 21.50 21.50 0.0
AEPS (Rs/share) 500.4 483.2 (3.4) 560.7 541.4 (3.4) 617.0 595.8 (3.4)
Target Price (Rs/share) 20,000 20,000 -
Shree Cement
To factor in the weak demand and pricing scenario across south and Maharashtra markets, we reduce vol est for FY20/21/22E by 4-5% and NSR by ~1-2% each. Thus, we lower EBITDA estimates by 15/14/12% each, leading to lower TP of Rs 120 (8x Sep’21E EBITDA).
While we maintain our revenue/EBITDA/PAT estimates, we trim EPS by 3% each to factor in the impact of 3% equity dilution on the recently concluded QIP in 3QFY20. We maintain out TP of Rs20,000 (15x Sep’ 21E EBITDA).
Source: Company, HDFC sec Inst Research
16
3QFY20E RESULTS PREVIEW
Stock Price Performance
Company Price Performance (absolute)
1w 1m 3m 6m 12m
Nifty (0.5) 2.3 8.0 5.7 12.5
UltraTech Cement 3.4 5.7 8.5 (2.5) 15.0
Shree Cement 7.5 12.3 23.4 7.6 39.6
Ambuja Cements 1.3 4.1 8.1 (1.5) (2.3)
ACC (0.5) 0.8 1.3 (4.4) 2.2
Ramco Cements 4.4 2.8 13.8 3.1 28.3
Dalmia Bharat (2.1) (3.9) 4.0 (19.2) N/A
JK Cements 4.4 10.7 21.5 30.7 82.3
Star Cement (0.4) 4.3 3.2 (18.5) (9.1)
JK Lakshmi 5.0 14.5 11.3 (6.5) 5.0
Orient Cement 7.1 13.0 (7.2) (20.4) 3.2
Deccan Cement 12.5 14.8 (2.7) (14.5) (16.4)
Source: Company, HDFC sec Inst Research
17
3QFY20E RESULTS PREVIEW
Peer Set Comparison
Source: Company, HDFC sec Inst Research, ^The corresponding financial years are CY18/19/20, 1 USD =Rs65 assumed
Company Mcap
(Rs bn) CMP
(Rs/sh) Reco TP
EV/EBITDA (x) EV/MT (USD) Net D:E (x) RoE (%)
FY19 FY20E FY21E FY19 FY20E FY21E FY19 FY20E FY21E FY19 FY20E FY21E
UltraTech Cement 1,205 4,388 BUY 5,350 19.4 14.4 13.2 193 191 185 0.6 0.5 0.3 8.3 12.2 11.9
Shree Cement 795 22,815 NEU 20,000 28.8 20.8 18.2 297 281 262 0.0 (0.3) (0.3) 13.5 15.1 13.7
Ambuja Cements ^ 413 208 BUY 240 13.9 11.8 10.6 136 133 122 (0.7) (0.7) (0.7) 5.9 6.4 6.7
ACC ^ 279 1,486 BUY 1,940 11.7 10.0 8.8 120 116 113 (0.3) (0.4) (0.4) 11.0 13.1 13.7
Ramco Cements 189 803 BUY 850 19.7 15.8 13.9 190 174 164 0.3 0.4 0.3 12.1 15.3 15.2
Dalmia Bharat 155 803 BUY 1,275 9.7 8.5 8.5 109 111 92 0.3 0.3 0.3 2.8 2.8 2.5
JK Cements 98 1,274 BUY 1,523 14.2 10.7 9.5 124 104 105 0.8 1.0 0.9 10.5 14.9 15.2
Star Cement 39 93 BUY 135 8.5 8.6 6.8 160 132 116 (0.1) (0.1) (0.2) 17.9 16.7 17.7
JK Lakshmi 38 319 BUY 483 12.0 7.0 6.3 70 68 68 0.8 0.6 0.5 5.3 15.7 17.2
Orient Cement 16.9 82 BUY 120 9.4 8.0 6.8 57 56 55 1.2 1.1 0.9 4.6 7.4 11.1
Deccan Cement 4.66 332 BUY 520 4.1 5.0 4.7 27 30 36 (0.2) (0.1) 0.1 11.9 11.5 12.1
18
3QFY20E RESULTS PREVIEW
Rating Definitions
BUY :Where the stock is expected to deliver more than 10% returns over the next 12 month period
NEUTRAL :Where the stock is expected to deliver (-) 10% to 10% returns over the next 12 month period
SELL :Where the stock is expected to deliver less than (-) 10% returns over the next 12 month period
Disclosure: We, Rajesh Kumar Ravi, MBA & Saurabh Dugar, MBA authors and the names subscribed to this report, hereby certify that all of the views expressed in this research report accurately reflect our views about the subject issuer(s) or securities. HSL has no material adverse disciplinary history as on the date of publication of this report. We also certify that no part of our compensation was, is, or will be directly or indirectly related to the specific recommendation(s) or view(s) in this report. Research Analyst or his/her relative or HDFC Securities Ltd. does not have any financial interest in the subject company. Also Research Analyst or his relative or HDFC Securities Ltd. or its Associate may have beneficial ownership of 1% or more in the subject company at the end of the month immediately preceding the date of publication of the Research Report. Further Research Analyst or his relative or HDFC Securities Ltd. or its associate does not have any material conflict of interest. Any holding in stock – No HDFC Securities Limited (HSL) is a SEBI Registered Research Analyst having registration no. INH000002475. Disclaimer: This report has been prepared by HDFC Securities Ltd and is solely for information of the recipient only. The report must not be used as a singular basis of any investment decision. The views herein are of a general nature and do not consider the risk appetite or the particular circumstances of an individual investor; readers are requested to take professional advice before investing. Nothing in this document should be construed as investment advice. Each recipient of this document should make such investigations as they deem necessary to arrive at an independent evaluation of an investment in securities of the companies referred to in this document (including merits and risks) and should consult their own advisors to determine merits and risks of such investment. The information and opinions contained herein have been compiled or arrived at, based upon information obtained in good faith from sources believed to be reliable. Such information has not been independently verified and no guaranty, representation of warranty, express or implied, is made as to its accuracy, completeness or correctness. All such information and opinions are subject to change without notice. Descriptions of any company or companies or their securities mentioned herein are not intended to be complete. HSL is not obliged to update this report for such changes. HSL has the right to make changes and modifications at any time. This report is not directed to, or intended for display, downloading, printing, reproducing or for distribution to or use by, any person or entity who is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, publication, reproduction, availability or use would be contrary to law or regulation or what would subject HSL or its affiliates to any registration or licensing requirement within such jurisdiction. If this report is inadvertently sent or has reached any person in such country, especially, United States of America, the same should be ignored and brought to the attention of the sender. This document may not be reproduced, distributed or published in whole or in part, directly or indirectly, for any purposes or in any manner. Foreign currencies denominated securities, wherever mentioned, are subject to exchange rate fluctuations, which could have an adverse effect on their value or price, or the income derived from them. In addition, investors in securities such as ADRs, the values of which are influenced by foreign currencies effectively assume currency risk. It should not be considered to be taken as an offer to sell or a solicitation to buy any security. This document is not, and should not, be construed as an offer or solicitation of an offer, to buy or sell any securities or other financial instruments. This report should not be construed as an invitation or solicitation to do business with HSL. HSL may from time to time solicit from, or perform broking, or other services for, any company mentioned in this mail and/or its attachments. HSL and its affiliated company(ies), their directors and employees may; (a) from time to time, have a long or short position in, and buy or sell the securities of the company(ies) mentioned herein or (b) be engaged in any other transaction involving such securities and earn brokerage or other compensation or act as a market maker in the financial instruments of the company(ies) discussed herein or act as an advisor or lender/borrower to such company(ies) or may have any other potential conflict of interests with respect to any recommendation and other related information and opinions. HSL, its directors, analysts or employees do not take any responsibility, financial or otherwise, of the losses or the damages sustained due to the investments made or any action taken on basis of this report, including but not restricted to, fluctuation in the prices of shares and bonds, changes in the currency rates, diminution in the NAVs, reduction in the dividend or income, etc. HSL and other group companies, its directors, associates, employees may have various positions in any of the stocks, securities and financial instruments dealt in the report, or may make sell or purchase or other deals in these securities from time to time or may deal in other securities of the companies / organizations described in this report. HSL or its associates might have managed or co-managed public offering of securities for the subject company or might have been mandated by the subject company for any other assignment in the past twelve months. HSL or its associates might have received any compensation from the companies mentioned in the report during the period preceding twelve months from t date of this report for services in respect of managing or co-managing public offerings, corporate finance, investment banking or merchant banking, brokerage services or other advisory service in a merger or specific transaction in the normal course of business. HSL or its analysts did not receive any compensation or other benefits from the companies mentioned in the report or third party in connection with preparation of the research report. Accordingly, neither HSL nor Research Analysts have any material conflict of interest at the time of publication of this report. Compensation of our Research Analysts is not based on any specific merchant banking, investment banking or brokerage service transactions. HSL may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report. Research entity has not been engaged in market making activity for the subject company. Research analyst has not served as an officer, director or employee of the subject company. We have not received any compensation/benefits from the subject company or third party in connection with the Research Report. HDFC securities Limited, I Think Techno Campus, Building - B, "Alpha", Office Floor 8, Near Kanjurmarg Station, Opp. Crompton Greaves, Kanjurmarg (East), Mumbai 400 042 Phone: (022) 3075 3400 Fax: (022) 2496 5066 Compliance Officer: Binkle R. Oza Email: [email protected] Phone: (022) 3045 3600 HDFC Securities Limited, SEBI Reg. No.: NSE, BSE, MSEI, MCX: INZ000186937; AMFI Reg. No. ARN: 13549; PFRDA Reg. No. POP: 11092018; IRDA Corporate Agent License No.: HDF 2806925/HDF C000222657; SEBI Research Analyst Reg. No.: INH000002475; SEBI Investment Adviser Reg. No.: INA000011538; CIN - U67120MH2000PLC152193 Mutual Funds Investments are subject to market risk. Please read the offer and scheme related documents carefully before investing.
19
3QFY20E RESULTS PREVIEW
HDFC securities Institutional Equities Unit No. 1602, 16th Floor, Tower A, Peninsula Business Park, Senapati Bapat Marg, Lower Parel, Mumbai - 400 013 Board : +91-22-6171 7330 www.hdfcsec.com